-
Jack Daniels Parent Company, EA, Cognizant Among 6 Stocks That Shine When Nvidia Slips: Analysis
Friday, April 19, 2024 - 5:31am | 769Read More...Six S&P 500 stocks often experience a surge when shares of Nvidia Corporation (NASDAQ:NVDA) take a dip, an analysis by CNBC revealed. What Happened: The six U.S.-listed stocks that typically see a rise when Nvidia’s shares falter include Jack Daniel's distiller Brown-Forman Corporation (...
-
Looking For Amazon-Proof Stocks? Try Henry Schein
Friday, September 15, 2017 - 1:43pm | 455Read More...Amazon.com, Inc. (NASDAQ: AMZN) is reportedly looking to enter the medical supply industry, but analysts at Piper Jaffray aren't concerned this will disrupt Henry Schein, Inc. (NASDAQ: HSIC)'s business. Analyst Sarah James upgraded Henry Schein's stock from Neutral to Overweight with a...
-
Patterson's Growth, Market Share At Risk In The Years Ahead
Thursday, July 6, 2017 - 2:32pm | 462Read More...Patterson Companies, Inc. (NASDAQ: PDCO), a distributor of consumable dental products and other services, is expected to see pressure in the coming years to its growth profile and market share take, according to analysts at Stifel. Stifel's Jonathan Block downgrades Patterson's stock rating from...
-
Patterson Earnings Preview: Continued Revenue Growth Seen
Monday, November 19, 2012 - 1:16pm | 545Read More...Patterson Companies (NASDAQ: PDCO), whose CEO was just named chairman of the Dental Trade Alliance, is scheduled to report its second-quarter fiscal 2013 results Tuesday, November 20, before the opening bell. Investors will be looking for the company to build on three-straight revenue increases and...
-
Goldman Sachs Maintains Buy on Henry Schein
Wednesday, June 8, 2011 - 9:29am | 83Read More...Goldman Sachs is out with its report today on Henry Schein (NASDAQ: HSIC), maintaining Buy. In a note to clients, Goldman Sachs writes, "We hosted and Q&A session and investor dinner with Steven Paladino, EVP and CFO and Ferdinand Jahnel, VP and Treasurer where commentary on the company's key...
-
JP Morgan Raises PT On Henry Schein To $72
Wednesday, May 4, 2011 - 6:25am | 27Read More...JP Morgan has raised the price target on Henry Schein (NASDAQ: HSIC) from $63 to $72 and maintains its Neutral rating.
-
J.P. Morgan Maintains Neutral Rating On HSIC
Wednesday, February 23, 2011 - 8:28am | 116Read More...Yesterday morning, Henry Schein, Inc. (NASDAQ: HSIC) reported 4Q10 EPS of $1.00, “above our $0.94 estimate and Bloomberg consensus of $0.96,” J.P. Morgan reports. “In addition, the company reaffirmed the prior 2011 EPS guidance,” J.P. Morgan writes. “We continue to remain cautious on HSIC given the...
-
HSIC Top-Line Results Were Solid, Goldman Sachs Reports
Tuesday, February 22, 2011 - 10:50am | 150Read More...Henry Schein, Inc. (NASDAQ: HSIC) reported 4Q EPS of $1.00 “vs. our estimate and consensus at $0.96,” Goldman Sachs reports. “Relative to our model, top-line results were solid although COGS was considerably ahead of our estimate, while the bottom line was helped by below the line items (i.e....
-
Sluggish Growth For Henry Schein, Share Values Decline
Monday, November 1, 2010 - 8:07am | 135Read More...Jefferies & Co. has published a research report on Henry Schein (NASDAQ: HSIC) after the company reported EPS guidance in-line with consensus, but still managed to disappoint investors. In the report, Jefferies writes "Management established 2011 EPS guidance in a range of $3.88-$3.98 (10%-13%...
-
Healthcare Distribution Earnings Preview
Tuesday, October 19, 2010 - 8:02am | 251Read More...JP Morgan has published a research report on Healthcare Technology & Distribution reporting on an earnings preview for 3Q and thoughts heading into the quarter. In the report, JP Morgan writes "In our view, the longer-term fundamentals for the PBM industry continue to remain very strong, as we...
